Efficacy of hepatitis B vaccine in susceptible spouses of chronic hepatitis B virus infected individuals at the time of marriage.

نویسندگان

  • Mohammad R Roushan
  • Hayedeh Samie
  • Mohammad J S Amiri
چکیده

OBJECTIVE To evaluate the efficacy of hepatitis B virus (HBV) vaccine in susceptible spouses at the time of marriage. METHODS From April 2003 to December 2005, 60 cases of susceptible wives of infected husbands and 32 cases of susceptible husbands of the infected wives in Babol north of Iran, received recombinant hepatitis B (HB) vaccine at the time of marriage followed with the second and third doses at 1, and 6 months. Post vaccination tests for hepatitis B surface antigen (HBsAg), anti-HBs and anti-hepatitis B core (HBc) were assessed 2 months of the later dose. The HBs antibody levels of > or = 10 mIU/ml was considered to be protective. Those with anti-HBs levels of <10 mIU/l received the second series of HBV vaccination. RESULTS The mean age of the infected husbands was 26.4 +/- 6 years and for infected wives were 22.7 +/- 4.7 years. Seventy (76.1%) cases were HBsAg and anti-hepatitis B e (HBe) positive. Among the recipients of vaccine, the mean age of females was 19 +/- 3.8 years and in males was 25.2 +/- 4.8 years (p=0.007). The HBs antibody levels of > or = 10 mIU/ml were detected in 79 (85.9%) cases. The HBs antibody levels of >100 mIU/ml were developed in 76.7% males and in 75% females (p=0.430). Twelve (13%) cases were non-responder and among them 11 (91.7%) cases responded to the second course of HBV vaccination. The HBs and HBc antibodies were developed in one case. CONCLUSION This study shows that administration of hepatitis B vaccine at the time of marriage prevents the transmission of hepatitis B virus in susceptible spouses.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

ایمن‌ سازی‌ هپاتیت‌ B

One of the most serious kinds of hepatitis is hepatitis B. This condition is more common than AIDS, and is 100 time more contagious. In Iran the most common cause of acute and chronic hepatitis, liver cirrhosis, and also hepatocellar carcinoma in adults, is hepatitis B. more than two billion people are infected and more than 350 million of individuals are carriers of this virus in the entire wo...

متن کامل

Hepatitis B infection: review article

Hepatitis B virus (HBV) is an etiological agent of hepatitis B infection. Hepatitis B is a life-threatening disease that affects the liver. The clinical outcomes of the disease are varied from asymptomatic disease to serious complication such as cirrhosis and hepatocellular carcinoma (HCC). Despite availability of the vaccine and appropriate treatment, hepatitis B infection still remains a majo...

متن کامل

تعیین میانگین تیتر Anti-HBS ایجاد شده در کارکنان بهداشتی دریافت کننده واکسن هپاتیت B در بیمارستان فیروزگر شهر تهران

Hepatitis B virus(HBV) is a major cause of viral hepatitis, cirrhosis and liver cancer worldwide and it is estimated to cause one million death worldwide annually. This virus is the second hazardous carcinogen in the world after smoking. According to WHO report 37% of the people in the world are infected by HBV. Healthcare workers(HCWs) are one of the high risk groups in affecting a...

متن کامل

Detection of SENV Virus in Healthy, Hepatitis B- and Hepatitis C-Infected Individuals in Yazd Province, Iran

Background: SEN virus (SENV) is the latest virus proposed as a cause of unknown hepatitis cases. Among nine detected genotypes of the virus, genotypes D and H are more frequent in hepatitis cases of unknown origin. The aim of this study was to determine the frequency of SENV-D and SENV-H genotypes in the sera of healthy individuals and hepatitis B and C patients. Methods: Totally, 200 serum sam...

متن کامل

Immunity to Hepatitis B Vaccine in Thalassaemic Patients based on the Time Passed from Vaccination

Background & Aims: Hepatitis B virus is one of the causes of acute and chronic hepatitis. Due to multiple hospitalization and blood transfusion, thalassaemic patients are at higher risk of this infection. Duration of the immunity after vaccination in this high-risk group and the need for booster vaccination is uncertain. The aim of this study was to find antibody titration and immunity to Hepat...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Saudi medical journal

دوره 28 4  شماره 

صفحات  -

تاریخ انتشار 2007